2.Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review
Suguru KADOMOTO ; Kazuyoshi SHIGEHARA ; Hiroaki IWAMOTO ; Hiroshi YAEGASHI ; Kouji IZUMI ; Yoshifumi KADONO ; Atsushi MIZOKAMI
The World Journal of Men's Health 2020;38(1):132-136
3.Type II Respiratory Failure with Systemic Sclerosis/Polymyositis Overlap Syndrome:A Case Report of Successful Respiratory Rehabilitation Therapy
Takashi OKADA ; Izumi KADONO ; Suzuna KONNO ; Junya SUGIYAMA ; Aika HISHIDA ; Yoshihiro NISHIDA ; Hideshi SUGIURA
The Japanese Journal of Rehabilitation Medicine 2020;():18038-
Introduction:Respiratory failures are categorized into types I and II. To our knowledge, we report the first case of pulmonary rehabilitation in a patient with systemic sclerosis/polymyositis overlap syndrome who developed type II respiratory failure.Methods:The patient was a 77-year-old woman who had received treatment for systemic sclerosis and polymyositis at another hospital. When she visited our hospital to obtain a second opinion, she suddenly lost consciousness and underwent trachea intubation because of typeⅡrespiratory failure. She received physical therapy on the third day of hospitalization and underwent a tracheotomy on the 16th day. As her thoracic movement was markedly restricted, we started physical training. After she was weaned off from the ventilator on the 43rd day, we performed muscular strength training and aerobic exercise. No exacerbation of CO2 storage was observed even if chest motion training was performed. She was discharged on the 72nd day and advised to wear retina®.Administration of therapeutic drugs such as steroids was maintained at the same dose.Conclusion:Physical therapy, such as chest mobilization, was effective for marked restriction of chest movement in a patient who had both polymyositis and systemic sclerosis.
4.Type II Respiratory Failure with Systemic Sclerosis/Polymyositis Overlap Syndrome:A Case Report of Successful Respiratory Rehabilitation Therapy
Takashi OKADA ; Izumi KADONO ; Suzuna KONNO ; Junya SUGIYAMA ; Aika HISHIDA ; Yoshihiro NISHIDA ; Hideshi SUGIURA
The Japanese Journal of Rehabilitation Medicine 2020;57(5):468-473
Introduction:Respiratory failures are categorized into types I and II. To our knowledge, we report the first case of pulmonary rehabilitation in a patient with systemic sclerosis/polymyositis overlap syndrome who developed type II respiratory failure.Methods:The patient was a 77-year-old woman who had received treatment for systemic sclerosis and polymyositis at another hospital. When she visited our hospital to obtain a second opinion, she suddenly lost consciousness and underwent trachea intubation because of typeⅡrespiratory failure. She received physical therapy on the third day of hospitalization and underwent a tracheotomy on the 16th day. As her thoracic movement was markedly restricted, we started physical training. After she was weaned off from the ventilator on the 43rd day, we performed muscular strength training and aerobic exercise. No exacerbation of CO2 storage was observed even if chest motion training was performed. She was discharged on the 72nd day and advised to wear retina®.Administration of therapeutic drugs such as steroids was maintained at the same dose.Conclusion:Physical therapy, such as chest mobilization, was effective for marked restriction of chest movement in a patient who had both polymyositis and systemic sclerosis.
5.A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age.
Hiroaki IWAMOTO ; Kouji IZUMI ; Suguru KADOMOTO ; Tomoyuki MAKINO ; Renato NAITO ; Hiroshi YAEGASHI ; Kazuyoshi SHIGEHARA ; Yoshifumi KADONO ; Atsushi MIZOKAMI
Asian Journal of Andrology 2021;23(1):36-40
A standard modality for prostate cancer detection in men 75 years and older has not been established. A simple screening method for elderly patients is needed to avoid unnecessary biopsies and to effectively diagnose prostate cancer. A retrospective study was conducted on elderly patients who had prostate biopsy at Kanazawa University Hospital (Kanazawa, Japan) between 2000 and 2017. Of the 2251 patients who underwent prostate biopsy, 254 had clinically significant prostate cancer (CSPC) with a Gleason score (GS) of≥7 and 273 had a GS of <7 or no malignancy. In this study, patients aged 75 years or older were classified as elderly patients. GS ≥ 7 was characterized by a prostate-specific antigen (PSA) of the maximum area under the curve of 12 ng ml